OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

CheckMate 77T: ctDNA Clearance and MRD Refine Risk After Perioperative Nivolumab

TRUMPET Registry: mCRPC Treatment and Outcomes by Race, Initial Diagnosis, and Family History

TP53-Mutated MDS: Can New Therapies Change the Prognosis?

Danny Burke: Study Identifying 272 Ongoing Cancer Clinical Trials in Brazil

Benny Johnson: Excited to Join Bristol Myers Squibb as Executive Director, Late-Stage Oncology for GI Cancers

Oncology News, Insights, Stories by OncoDaily

100 Influential People in Oncology
OncoDaily 100

100 Influential People in Oncology 2026 – Nominations are Open!

OncoSil
FDA Approvals

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

Overcoming Barriers in Geriatric Oncology
Community

Geriatric Oncology in Brazil: Overcoming The Barriers to High-Quality Cancer Care For Older Adults

Cancer Planners Forum 2026: Strengthening National Cancer Control Plans Worldwide

Lenox Hill Hospital’s Brain Tumor Center Gala Raises More Than $1.6 Million to Advance Brain Tumor Research

Lacy Hubbard: What Happens After You Screen Nearly Half a Million Women?

Swim Against Cancer: Bartłomiej Kubkowski’s Historic 160-Km Baltic Crossing

Zainab Shinkafi-Bagudu: Nigeria Surpasses 17 Million HPV Vaccinations in Push to Eliminate Cervical Cancer

Herbert Loong: Optimizing Datopotamab Deruxtecan Safety in Advanced NSCLC

Angela Mastronuzzi: Book for Caring for the Child, Not Just the Tumor

Voices
IASLC

Congratulations to Alessandro Leonetti on Receiving the Young Investigator Grant - IASLC

Gilberto Lopes: Examining the Longevity Industry’s Faustian Bargain

Shane Jacobson: The War on Tobacco Is Not Over

Christopher Jackson: Proud to Stand for Re-Election to the UICC Board of Directors

Amy Shelly: I’m Supporting Daffodil Day Because I’ve Seen the Difference

Ruben Mesa: Atrium Health Wake Forest Baptist Members Had Their 'Advance' Today

Guilherme Nader Marta: Has Been a Privilege to be Part of Dana-Farber and Harvard Medical School

FDA Approvals
OncoSil

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

ESSO Advanced Course on the Management of HIPEC after CRS

European Society of Surgical Oncology

03 Feb
HIPEC

The ESSO-KBCS Course on Minimally Invasive Breast Surgery

European Society of Surgical Oncology

15 Jan
ESSO-KBCS Course

Transforming Care for Medically Complex Children - NYU Langone Health

NYU Langone Health

09 Oct
NYU Langone Health

Orthopaedic Manual Therapy: Lower Extremity Track 2026

NYU Langone Health

19 Sep
NYU Langone Health

The 6th Annual NYU Langone Health Oncology Rehabilitation Summit

NYU Langone Health

25 Sep
Oncology Rehabilitation Summit

Immune-oncology
Tumor Mutational Burden in Immunotherapy: Why TMB Is More Than a Number

Tumor Mutational Burden in Immunotherapy: Why TMB Is More Than a Number

CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

Hypoxia and Immunotherapy Resistance: Can HIF Targeting Improve Response?

In Vivo CAR-T Cell Therapy: Clinical Proof of Concept and the Rising Role of AI

Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Gastrointestinal-Oncology
PLATFORM

PLATFORM: Maintenance Rucaparib in Advanced HER2-Negative Esophagogastric Adenocarcinoma

10 Must-Read Posts In GI Oncology This Week

5 Messages Shaping GI Oncology After ESMO GI 2026: Highlighted by Maria Maddalena Laterza

CAVE and CAVE-2 GOIM Studies: Predictive biomarkers for Cetuximab-Based Rechallenge in mCRC

NETTER-2: First-Line [177Lu]Lu-DOTA-TATE plus Octreotide in Advanced G2-G3 GEP-NETs

Daraxonrasib Resistance in Pancreatic Cancer Points to New Combination Strategies

Five-Year CheckMate 648 Follow-Up: Nivolumab-Based Therapy in Advanced ESCC

Breast-Oncology
HER2DX

HER2DX in Early HER2-Positive Breast Cancer: Toward Biology-Guided Treatment Intensity

Breast Cancer in 2026: Molecular Interception, MRD, ADC Sequencing and De-Escalation

Tissue-Free ctDNA Detects MRD Before TNBC Recurrence

Rare Triple-Negative Breast Cancer Is Not One Disease

Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy

Rb-Driven Transcription Reveals a CDK4/6 Paradox in Breast Cancer

ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps

Lung-Oncology
CheckMate 77T

CheckMate 77T: ctDNA Clearance and MRD Refine Risk After Perioperative Nivolumab

DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC

REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC

SYS6010 Shows Encouraging Activity Across Pretreated NSCLC

Rilvegostomig NSCLC: 5 Major Promising Findings From ARTEMIDE-01

Air Pollution and Lung Cancer: Critical Metabolic Clues

Transformed SCLC in EGFR-Mutant NSCLC: Critical Progress in a High-Risk Setting

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
BeOne

BeOne, BeOne Care Foundation and The Max Foundation Renew BRUKINSA Access Partnership for CLL in LMICs

TP53-Mutated MDS: Can New Therapies Change the Prognosis?

Novel Combinations in Myelofibrosis: Advancing Beyond the JAK Inhibitor Backbone

FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR

Artificial Intelligence and Digital Pathology in Leukemia Diagnosis

Treatment-Free Remission (TFR) in CML: Who, When, and How?

The Next Frontier in R/R ALL: CAR-T, Bispecifics, and Emerging Strategies

Radiotherapy
10 Must-Read Posts In Radiotherapy This Week: August 10-16

10 Must-Read Posts In Radiotherapy This Week: August 10-16

Mayo Clinic Reports First Clinical Series of Minibeam Radiation Therapy for Superficial Malignancies

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

ESTRO Breast Radiotherapy Target Volumes Prospectively Validated in DBCG Skagen Trial 1

10 Must-Read Posts In Radiotherapy This Week: August 2 -9

DBCG Skagen Trial 1 Validates ESTRO Target Volume Guidelines in Early Breast Cancer

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

OncoDaily TV
Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessable for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Not To Miss
FDA

FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand

Mammo 2026: Global Breast Cancer Leaders to Meet for Two-Day Virtual Congress

Cancer Planners Forum 2026: Strengthening National Cancer Control Plans Worldwide

10 Major Cancer Research Grants Offering $1M+

The 7th Emirates Oncology Society Annual Conference 2026

ACS National Lung Cancer Roundtable Sets Priorities for Advanced Imaging in Lung Cancer

Top 10 OncoGrants This Week: Major Funding Opportunities Across Cancer Research

OncoGrants
Early Detection and Diagnosis

Cancer Research UK Early Detection and Diagnosis Primer Award 2026

Clinical Research Funding

Cancer Research UK Clinical Research Funding Scheme 2026

Clinical Future Leaders Fellowship

Cancer Research UK Clinical Future Leaders Fellowship 2026

Pre-doctoral Research Bursary

Cancer Research UK Pre-doctoral Research Bursary 2026

Early Detection and Diagnosis

Cancer Research UK Early Detection and Diagnosis Project Award 2026

Blood Cancer

Blood Cancer United Equity in Access Research Grant 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Antonio Lázaro Sánchez

Antonio Lázaro Sánchez

Oncologists Location El Palmar, Spain
Karima Oualla

Karima Oualla

Oncologists Location Fès, Morocco
Abeid Athman Omar

Abeid Athman Omar

Oncologists Location Nairobi, Kenya
Roupen Odabashian

Roupen Odabashian

Oncologists Location Detroit, USA
Garik Sagoyan

Garik Sagoyan

Oncologists Location , USA
Naveen Kumar

Naveen Kumar

Oncologists Location Thiruvananthapuram, India
Dirk Arnold

Dirk Arnold

Oncologists Location Hamburg, Germany
Siddharth Sreemahadevan

Siddharth Sreemahadevan

Oncologists Location Thalassery, India

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Pashtoon Kasi

Pashtoon Kasi: Pharmacokinetics and Pharmacodynamics of Localized Intra-Arterial Gemcitabine

Matt Manning

Matt Manning: 3-Year Disease-Free Survival Rate for Intermediate-Risk Prostate Cancer

Aleix Prat

Aleix Prat: Ribociclib Plus Endocrine Therapy in High-Risk HR+/HER2-Negative Breast Cancer

Andrea Cosenza

Andrea Cosenza: Focal Therapy in Patients With Nonmetastatic Prostate Cancer

Paolo Tarantino: T-DXd Improves PFS in First-Line HER2-Mutant NSCLC

Paolo Tarantino: T-DXd Improves PFS in First-Line HER2-Mutant NSCLC

Marco Davila

Marco Davila: We Need to Do a Better Job Delivering CAR T to Patients

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries